NITD-349

CAS No. 1473450-62-2

NITD-349 ( NITD349 )

Catalog No. M12026 CAS No. 1473450-62-2

NITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 41 Get Quote
5MG 65 Get Quote
10MG 110 Get Quote
25MG 200 Get Quote
50MG 335 Get Quote
100MG 500 Get Quote
500MG 1098 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    NITD-349
  • Note
    Research use only, not for human use.
  • Brief Description
    NITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv.
  • Description
    NITD-349 is a novel, orally bioavailable mycobacterial membrane protein Large 3 (MmpL3) inhibitor with MIC of 23 nM against M tuberculosis H37Rv; shows potent activity against both drug-sensitive and multidrug-resistant clinical isolates of Mtb; demonstrates effectivity in treating both acute and chronic Mtb infections in mouse efficacy models.
  • Synonyms
    NITD349
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Antibacterial
  • Research Area
    Infection
  • Indication
    ——

Chemical Information

  • CAS Number
    1473450-62-2
  • Formula Weight
    306.36
  • Molecular Formula
    C17H20F2N2O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : ≥ 310 mg/mL 1011.91 mM
  • SMILES
    CC1(CCC(CC1)NC(=O)C2=CC3=C(N2)C=C(C=C3F)F)C
  • Chemical Name
    N-(4,4-dimethylcyclohexyl)-4,6-difluoro-1H-indole-2-carboxamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Rao SP, et al. Sci Transl Med. 2013 Dec 4;5(214):214ra168.
molnova catalog
related products
  • Benzoylacetone

    Benzoylacetone exhibits antibacterial activity.

  • ML406

    ML406 is a small molecule Mtb bioA (DAPA synthase) enzyme inhibitor (IC50=30 nM) that shows anti-tubercular activity.

  • AAI-101

    AAI-101 is a novel extended-spectrum β-lactamase inhibitor with activity against many β-lactamases, including some class A and class D carbapenemases.